Skip to main content
. 2014 Feb 13;6:ecurrents.hd.3304e87e460b4bb0dc519a29f4deccca. [Version 1] doi: 10.1371/currents.hd.3304e87e460b4bb0dc519a29f4deccca

Pharmacokinetic (PK) analysis of SCH-51866 after acute administration in mice.

Pharmacokinetic (PK) analysis of SCH-51866 after acute administration in mice.

(A) Exposure of SCH-51866 in plasma following IV (5 mg/kg) or oral (10 mg/kg) administration; (B) Exposure of SCH-51866 in plasma and brain tissue after oral (PO) (10 mg/kg) dosing.